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CASE REPORT
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Cutaneous metastases from internal malignancies are, 
occurring in 0.5% to 9% of cases. Lung, breast, and 
colorectal cancers are common primary tumors that 
metastasize to the skin; cutaneous metastasis usually occurs 
on the chest wall and abdomen as asymptomatic nodular 
patterns. Esophageal cancer is not nearly as common as 
breast, lung, and colorectal cancers, and esophageal cancer 
rarely metastasizes to the skin. Cutaneous metastasis of 
esophageal cancer is rare and metastasis to the scalp is 
extremely rare. Only a few cases of cutaneous metastases of 
esophageal cancer have been reported in Korea. Most of the 
cases involved cutaneous metastases arising from 
esophageal squamous cell carcinoma; however, there have 
been several reports describing cutaneous metastases from 
esophageal adenocarcinomas. Herein, we describe a case of 
metastatic skin cancer that originated from esophageal 
adenocarcinoma. (Ann Dermatol 21(2) 164∼167, 2009)
-Keywords-
Adenocarcinoma, Esophagus, Metastasis, Scalp
INTRODUCTION
Cutaneous metastases from internal malignancies occur in 
0.5% to 9% of cases. Such cutaneous metastases occur at 
any age, but most frequently arise in the 6th and 7th deca-
des of life1,2. They usually originate from cancers of the 
breast, lung, and large bowel2. Cutaneous metastases most 
often present as asymptomatic, firm nodules. The scalp is 
an unusual site of cutaneous metastases and the clinical 
manifestations usually include nodules or alopecia neo-
plastica3.
Esophageal cancer has a poor prognosis and seldom meta-
stasizes to the skin. In fact, the skin accounts for only 1% 
of the metastatic sites for esophageal cancer4. In Western 
countries, the incidence of esophageal adenocarcinoma 
has increased to 50% of all esophageal cancers, but has 
not increased in Asia, including Korea5. We report an un-
usual case of a patient who presented with a hard nodule 
on the scalp which was diagnosed as metastatic esoph-
ageal adenocarcinoma.
CASE REPORT
A 58-year-old Korean woman presented with dysphagia 
and dyspepsia for 4∼5 months. An endoscopy was per-
formed and biopsies were obtained from the tumor, which 
was adjacent to the gastroesophageal junction. The patient 
was diagnosed with esophageal adenocarcinoma based 
upon the histopathologic findings. Metastases of esoph-
ageal adenocarcinoma to the right third anterior rib and 
the aortocaval lymph nodes were noted through positron 
emission tomography-computed tomography (PET-CT). 
The patient underwent a total esophago-gastrectomy and 
received adjuvant chemotherapy and radiotherapy. 
Seven months later, she visited the Department of 
Dermatology with a hard nodule which had developed on 
the occipital area of the scalp 2 weeks earlier. Physical ex-
amination revealed a flesh-colored 1 cm sized nodule on 
the occipital area (Fig. 1). The histopathologic findings 
showed multiple poorly differentiated cystic and ductal 
spaces lined with atypical epithelial cells, suggestive of 
glandular formation in the dermis (Fig. 2A). Basophilic 
mucoid stromal tissues surrounding the tumor cells were 
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Fig. 1. 1 cm sized flesh-colored hard nodule on the occipital 
area of the scalp.
Fig. 2. (A) Multiple poorly differentiated cystic and ductal spaces lined with atypical epithelial cells forming a glandular structure 
in the dermis (H&E, ×40). (B) At high power magnification, cytologic atypia with pleomorphic and hyperchromatic nuclei and apoptotic
necrosis were observed (H&E, ×100). (C) The tumor cells show immunoreactivity with CEA (CEA, ×100). (D) Immunohistochemical 
staining shows diffuse membrane staining with EMA (EMA, ×100).
observed. At high power magnification, the specimen re-
vealed cytologic atypia with pleomorphic and hyper-
chromatic nuclei (Fig. 2B). To evaluate the primary origin 
of the nodule, special stains and immunohistochemical 
studies were performed. The tumor cells were stained 
with alcian blue and periodic acid-schiff (PAS). In addi-
tion, carcinoembryonic antigen (CEA) and epithelial mem-
brane antigen (EMA) were positive (Figs. 2C and D). The 
serum CEA level was elevated to 14.76 ng/mL (normal val-
ue, 0∼5 ng/mL), while the CA 19-9 level was within nor-
mal limits.
DISCUSSION
Skin metastases from internal malignancies are uncom-
mon and sometimes are the first presentation of a carcino-
ma with a poor prognosis. In Korea, the incidence of cuta-
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neous metastases from internal malignancies has been re-
ported to be between 0.11% and 1.1%6-8. In most cases, 
cutaneous metastases occur during the course of meta-
chronous metastases, and develop 2.9 years later on aver-
age9. The median survival of patients with squamous cell 
carcinoma has been reported to be 4.7 months after cuta-
neous metastasis10. The clinical appearances of metastatic 
cutaneous lesions include inflammatory papules and 
patches or erythematous, indurated plaques, or fixed sub-
cutaneous nodules, as in our case.
Esophageal cancer is one of the cancers associated with a 
high mortality rate. Esophageal cancer seldom meta-
stasizes to the skin. In a large study of 7,316 cancer pa-
tients with metastases to the skin, cutaneous metastasis 
from esophageal cancer was not observed11. In other large 
study involving cutaneous metastastatic cancers, there 
were three cases of esophageal cancer which had metasta-
sized to the skin. Among the cases, one was squamous 
cell carcinoma, another was adenocarcinoma, and the 
other was undifferentiated carcinoma12. Cutaneous meta-
stases of esophageal cancers are extremely rare, and Quint 
et al4 reported the incidence of cutaneous metastases of 
esophageal cancer to be 1%. All cases of esophageal ad-
enocarcinoma arising from Barrett esophagus as a compli-
cation of chronic gastroesophageal reflux occur at or near 
the gastroesophageal junction, as in our case13.
Until recently, squamous cell carcinoma was the most 
common histologic subtype of esophageal cancer. 
However, in recent decades there has been a rapid in-
crease in the incidence of esophageal adenocarcinoma in 
Western countries14. Cutaneous metastases of esophageal 
cancer are extremely rare; however, due to the widening 
spectrum of therapeutic alternatives and improving surviv-
al rates, metastatic disease has become more common15. 
According to a recent report, survival differences based on 
histology have been observed, and the adenocarcinoma 
subtype had a slightly longer survival rate16. They sug-
gested that the introduction of endoscopic surveillance 
programs for Barrett’s esophagus might explain the more 
pronounced improvement in survival among patients with 
adenocarcinoma compared to patients with squamous cell 
carcinoma. Since cutaneous metastatic esophageal cancer 
itself is rare, survival differences by histology in cutaneous 
metastatic esophageal carcinoma have not been investi-
gated. However, the two histologic subtypes cannot be 
distinguished based on clinical features.
The histopathologic features of cutaneous metastasis give 
physicians important clues in identifying primary malig-
nant tumors. Recently, immunohistochemical stains which 
detect antigens of tumors using specific antibodies have 
been widely used to identify primary tumors. Based on 
that rationale, we used various immunohistochemical 
stains to identify the origin of the metastases. CEA and 
EMA, which are common antigens in tumors, enabled us 
to identify the origin of the malignant tumor. The tumor 
cells reacted positively with alcian blue and PAS stains, 
which indicated that the tumor cells had components of 
mucin, mucoprotein, and glycogen. The immunohisto-
chemical findings in our case were sufficient to suggest 
esophageal adenocarcinoma as the origin of the primary 
tumor. CK7 and CK20 are often used to differentiate be-
tween Barrett’s esophagus and gastric cardiac intestinal 
metaplasia. Usually, CK7/20 is stained in the type C pat-
tern (weak patch stain with CK7; surface and crypt epi-
thelium with CK20) in Barrett’s esophagus, but no specific 
stain in gastric cardiac lesions17. Immunostaining with 
CK7/CK20 generally has moderate-to-high sensitivity and 
specificity in distinguishing metaplasic tissue of the esoph-
agus and stomach. However, there is controversy in the 
utilization of CK7/20 staining to differentiate primary tu-
mors because CK7/20 staining results in a lack of con-
sistency according to the literature18.
In the Korean literature, there have been only a few cases 
of cutaneous metastases from esophageal cancers. One 
cutaneous metastatic lesion appeared at the end of a digit 
as a papule19, another occurred on the lower lip as a nod-
ule20, and a third case presented on the scalp as a nod-
ule21. However, none of the cases were from esophageal 
adenocarcinoma, but were from squamous cell carcinoma 
of the esophagus. Although the lifestyle of Korean society 
has recently become westernized, the incidence of esoph-
ageal adenocarcinoma has not increased. Thus, metastatic 
skin cancer from esophageal adenocarcinoma might be 
exceedingly rare compared to Western countries. This 
case suggests that dermatologists should consider the pos-
sibility of cutaneous metastases in patients with esoph-
ageal adenocarcinomas. Herein, we have described the 
first case of metastatic skin cancer from esophageal ad-
enocarcinoma occurring on the scalp in the Korean 
literature.
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